驛探
3646
K Pharma
4896
Mirairo Inc.
335A
Aplix
3727
寫樂鋼筆
7992
(FY)2024/12/31 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | (FY)2022/12/31 | (Q4)2022/12/31 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 6.29%117.89億 | 6.18%30.35億 | 8.41%27.41億 | 16.04%110.91億 | 15.28%28.94億 | 14.47%28.1億 | 14.61%28.59億 | 20.46%25.29億 | -0.16%95.58億 | 6.72%25.1億 |
主營業務成本 | 6.42%98.79億 | 4.48%24.92億 | 5.41%23.12億 | 11.02%92.83億 | 11.97%23.16億 | 8.19%23.87億 | 9.96%23.86億 | 14.45%21.94億 | 5.72%83.61億 | 1.36%20.69億 |
毛利 | 5.63%19.1億 | 14.73%5.43億 | 28.01%4.29億 | 51.08%18.08億 | 30.80%5.77億 | 70.42%4.22億 | 45.69%4.73億 | 83.41%3.35億 | -28.10%11.97億 | 41.90%4.41億 |
營業費用 | 7.58%11.57億 | 2.96%2.91億 | 8.23%2.82億 | 10.63%10.75億 | 14.45%2.54億 | 5.22%2.78億 | 9.39%2.82億 | 14.58%2.61億 | 3.71%9.72億 | -11.22%2.22億 |
員工成本 | 0.13%4.48億 | ---- | ---- | 5.76%4.47億 | ---- | ---- | ---- | ---- | 15.37%4.23億 | ---- |
銷售、一般行政及管理費用 | 33.67%3.14億 | ---- | ---- | 16.88%2.35億 | ---- | ---- | ---- | ---- | 7.31%2.01億 | ---- |
-一般及行政管理費用 | 33.67%3.14億 | ---- | ---- | 16.88%2.35億 | ---- | ---- | ---- | ---- | 7.31%2.01億 | ---- |
其他營業費用 | 0.49%3.95億 | ---- | ---- | 12.93%3.93億 | ---- | ---- | ---- | ---- | -9.19%3.48億 | ---- |
營業利潤 | 2.77%7.53億 | 32.15%2.52億 | 97.31%1.47億 | 226.09%7.33億 | 47.32%3.23億 | 957.64%1.44億 | 186.05%1.91億 | 266.06%7,445.3萬 | -69.10%2.25億 | 258.61%2.2億 |
營業外利息收入與支出淨額 | -54.03%-2,792.7萬 | -19.49%-576.3萬 | -26.14%-566萬 | 10.38%-1,813.1萬 | -164.31%-1,005.7萬 | 123.54%123.6萬 | 13.91%-482.3萬 | 19.47%-448.7萬 | -129.20%-2,023萬 | -57.75%-380.5萬 |
營業外利息收入 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.97%92.8萬 | -64.04%87.3萬 |
營業外利息支出 | 54.03%2,792.7萬 | 19.49%576.3萬 | 26.14%566萬 | -14.31%1,813.1萬 | -6.80%436萬 | -15.93%446.1萬 | -13.91%482.3萬 | -19.47%448.7萬 | 1.79%2,115.8萬 | -3.35%467.8萬 |
投資淨收益 | 197.24%638.5萬 | -965.79%-651.2萬 | 72.31%-656.6萬 | -54.71%551萬 | 66.54%-327.8萬 | -818.7萬 | -61.1萬 | -227.73%-2,371.1萬 | 591.52%1,216.5萬 | |
被指定為現金流套期的金融工具損益 | ||||||||||
終止確認可供出售金融資產損益 | ||||||||||
聯營企業及其他參股權益產生的收益 | ||||||||||
特殊收入(費用) | -143.70%-1,524.6萬 | 96.39%-625.6萬 | -3,114.09%-1.73億 | |||||||
減:其他特殊費用 | --1,374.2萬 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 104.50%666.6萬 | ---- |
減:勾銷 | -75.96%150.4萬 | ---- | ---- | -96.24%625.6萬 | ---- | ---- | ---- | ---- | 16.81%1.66億 | ---- |
其他營業外收入(費用) | 2.16%2,008.1萬 | -48.61%490.6萬 | -57.18%271.6萬 | -83.64%1,965.7萬 | -73.82%320.3萬 | -97.52%56.5萬 | -84.74%954.6萬 | -71.83%634.3萬 | -56.70%1.2億 | -91.34%1,223.6萬 |
稅前利潤 | 2.06%7.36億 | 31.46%2.46億 | 81.57%1.37億 | 464.41%7.21億 | 370.70%3.16億 | 1,679.10%1.42億 | 88.35%1.87億 | 354.09%7,569.7萬 | -88.08%1.28億 | -59.13%6,711.2萬 |
所得稅 | 275.81%2.21億 | -210.98%-1億 | 8.23%351萬 | -33.09%-1.26億 | 10.11%-1億 | 3.39%317.5萬 | -557.86%-3,216.9萬 | -51.87%324.3萬 | -459.16%-9,463.4萬 | -823.54%-1.11億 |
除稅後利潤 | -39.24%5.15億 | 57.75%3.46億 | 84.86%1.34億 | 280.93%8.47億 | 133.00%4.16億 | 1,251.77%1.39億 | 137.44%2.2億 | 298.34%7,245.3萬 | -78.73%2.22億 | 20.00%1.79億 |
持續經營利潤 | -39.24%5.15億 | 57.75%3.46億 | 84.85%1.34億 | 280.93%8.47億 | 133.00%4.16億 | 1,251.77%1.39億 | 137.43%2.2億 | 298.35%7,245.4萬 | -78.73%2.22億 | 20.00%1.79億 |
歸屬于少數股東的淨利潤 | ||||||||||
歸屬於母公司的淨利潤 | -39.24%5.15億 | 57.75%3.46億 | 84.86%1.34億 | 280.93%8.47億 | 133.00%4.16億 | 1,251.77%1.39億 | 137.44%2.2億 | 298.34%7,245.3萬 | -78.73%2.22億 | 20.00%1.79億 |
優先股派息 | ||||||||||
其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
歸屬于普通股股東的淨利潤 | -39.24%5.15億 | 57.75%3.46億 | 84.86%1.34億 | 280.93%8.47億 | 133.00%4.16億 | 1,251.77%1.39億 | 137.44%2.2億 | 298.34%7,245.3萬 | -78.73%2.22億 | 20.00%1.79億 |
總派息金額 | ||||||||||
基本每股收益 | -39.31%49.57 | 57.51%33.36 | 84.55%12.9 | 280.62%81.68 | 132.73%40.1 | 1,246.15%13.41 | 137.18%21.18 | 298.02%6.99 | -78.80%21.46 | 20.15%17.23 |
稀釋每股收益 | -39.37%49.01 | 56.71%32.94 | 83.55%12.72 | 279.13%80.83 | 131.62%39.63 | 1,232.48%13.25 | 135.64%21.02 | 296.32%6.93 | -78.70%21.32 | 22.56%17.11 |
每股派息 | ||||||||||
貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |